Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fused triazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

Fused triazole derivatives as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes

US Patent 7625888 · Granted Dec 1, 2009

Estimated economic value: $78,669,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

AMPK activators2023
2′-alkynyl substituted nucleoside derivatives and methods of use thereof for the2017
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or2016
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of2016
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment of2015
Dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetes2015
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or2015
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or2014
Substituted aminopiperidines as dipeptidyl peptidase-IV inhibitors for the treat2014
Heterocyclic compounds as dipeptidyl peptidase-IV inhibitors for the treatment o2014
Aminotetrahydropyrans as dipeptidyl peptidase-IV inhibitors for the treatment or2013
Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of typ2013